FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, particularly to a DNA aptamer specific to glial brain tumour cells. Said aptamer has the sequence SEQ ID NO: 1 or SEQ ID NO: 2. Present invention also relates to a conjugate of said DNA aptamer with a fluorescent label, a composition containing said conjugate, as well as a method for intraoperative staining of glial brain tumour cells using such a composition.
EFFECT: invention provides high specificity and affinity of DNA aptamers to glioblastoma cells and high accuracy of determining true boundaries of said tumour during surgery.
16 cl, 11 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF VISUALIZATION OF HUMAN GLIOBLASTOMA | 2015 |
|
RU2654665C2 |
| METHOD FOR TUMOUR-SPECIFIC TARGET DETECTION IN HISTOLOGICAL SECTIONS OF HUMAN LUNG CANCER PATIENTS TISSUE | 2015 |
|
RU2639238C2 |
| APTAMER PASSING THROUGH MOUSE BLOOD-BRAIN BARRIER OF MOUSE BRAIN | 2016 |
|
RU2711912C2 |
| METHOD OF DETECTING CIRCULATING TUMOUR CELLS, MICROEMBOLI AND APOPTOTIC BODIES IN BLOOD OF LUNG CANCER PATIENTS | 2013 |
|
RU2571821C2 |
| CONJUGATE OF A FLUORESCENT DYE WITH A PEPTIDE SUBSTANCE WHICH CONTAINS A PSMA-BINDING LIGAND BASED ON A UREA DERIVATIVE FOR VISUALIZING CELLS EXPRESSING PSMA, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2019 |
|
RU2713151C1 |
| METHOD FOR ASSESSING THE AFFINITY OF AN OLIGONUCLEOTIDE | 2018 |
|
RU2700584C1 |
| APTAMER SPECIFIC TO HUMAN TUMOUR LUNG TISSUES | 2012 |
|
RU2528870C2 |
| MAGNETIC METAL OXIDE COATED POLYMER NANOPARTICLES AND USE THEREOF | 2008 |
|
RU2472530C2 |
| MEANS AND METHODS FOR CANCER TREATMENT AND/OR PREVENTION DEPENDING ON NATURAL AHR LIGAND | 2012 |
|
RU2640913C2 |
| METHOD FOR DETECTING AND LOCALISING GLIAL BRAIN TUMOURS INTRAOPERATIVELY | 2014 |
|
RU2561030C1 |
